SG11202012621VA - Dosage form comprising a live biotherapeutic product - Google Patents

Dosage form comprising a live biotherapeutic product

Info

Publication number
SG11202012621VA
SG11202012621VA SG11202012621VA SG11202012621VA SG11202012621VA SG 11202012621V A SG11202012621V A SG 11202012621VA SG 11202012621V A SG11202012621V A SG 11202012621VA SG 11202012621V A SG11202012621V A SG 11202012621VA SG 11202012621V A SG11202012621V A SG 11202012621VA
Authority
SG
Singapore
Prior art keywords
dosage form
live biotherapeutic
biotherapeutic product
product
live
Prior art date
Application number
SG11202012621VA
Other languages
English (en)
Inventor
Christophe Carite
Sophie Declomesnil
Original Assignee
4D Pharma Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1810061.0A external-priority patent/GB201810061D0/en
Priority claimed from GBGB1818740.1A external-priority patent/GB201818740D0/en
Application filed by 4D Pharma Res Ltd filed Critical 4D Pharma Res Ltd
Publication of SG11202012621VA publication Critical patent/SG11202012621VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202012621VA 2018-06-19 2019-06-19 Dosage form comprising a live biotherapeutic product SG11202012621VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1810061.0A GB201810061D0 (en) 2018-06-19 2018-06-19 Product
GBGB1818740.1A GB201818740D0 (en) 2018-11-16 2018-11-16 Product
PCT/GB2019/051720 WO2019243814A1 (fr) 2018-06-19 2019-06-19 Forme posologique comprenant un produit biothérapeutique vivant

Publications (1)

Publication Number Publication Date
SG11202012621VA true SG11202012621VA (en) 2021-01-28

Family

ID=67107909

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012621VA SG11202012621VA (en) 2018-06-19 2019-06-19 Dosage form comprising a live biotherapeutic product

Country Status (13)

Country Link
US (1) US20210196643A1 (fr)
EP (1) EP3810097A1 (fr)
JP (1) JP2021527639A (fr)
KR (1) KR20210021461A (fr)
CN (1) CN112312896A (fr)
AU (1) AU2019289190A1 (fr)
BR (1) BR112020025123A2 (fr)
CA (1) CA3103064A1 (fr)
IL (1) IL279190A (fr)
MX (1) MX2020013282A (fr)
SG (1) SG11202012621VA (fr)
TW (1) TW202007400A (fr)
WO (1) WO2019243814A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117797176A (zh) * 2024-03-01 2024-04-02 南京大学 双胞梭菌在制备治疗非酒精性脂肪性肝病药物中的应用和一种药物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2808689B1 (fr) 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
GB2418431A (en) * 2004-09-27 2006-03-29 Multigerm Uk Entpr Ltd Metabolically active micro organisms and methods for their production
US9492487B2 (en) * 2010-02-01 2016-11-15 Matthew Ryan Garner Microbial product containing multiple microorganisms
EP2632584B1 (fr) 2010-10-26 2017-08-09 Capsugel Belgium NV Procede pour la preparation des enrobages mucilagineux de capsules entériques
CN102210659B (zh) * 2011-06-02 2012-07-04 陕西巨子生物技术有限公司 一种双歧杆菌微胶囊及其制备方法
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN102960600A (zh) * 2012-11-19 2013-03-13 陕西科技大学 一种双层包埋双歧杆菌微胶囊的制备方法
CN102960598A (zh) * 2012-11-19 2013-03-13 陕西科技大学 一种三层包埋双歧杆菌微胶囊的制备方法
CN110917220A (zh) * 2013-02-04 2020-03-27 赛里斯治疗公司 治疗组合物及其使用方法
MA41010B1 (fr) * 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3206700T3 (pl) 2015-06-15 2019-11-29 4D Pharma Res Ltd Kompozycje zawierające szczepy bakteryjne
ME03003B (fr) 2015-11-20 2018-10-20 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS58869B1 (sr) * 2016-03-04 2019-08-30 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za lečenje visceralne hipersenzitivnosti
FI3468573T3 (fi) * 2016-06-14 2023-10-02 Vedanta Biosciences Inc Clostridium difficile -infektion hoito
TW201821093A (zh) * 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物

Also Published As

Publication number Publication date
CN112312896A (zh) 2021-02-02
WO2019243814A1 (fr) 2019-12-26
US20210196643A1 (en) 2021-07-01
IL279190A (en) 2021-01-31
MX2020013282A (es) 2021-02-22
AU2019289190A1 (en) 2021-01-07
TW202007400A (zh) 2020-02-16
CA3103064A1 (fr) 2019-12-26
EP3810097A1 (fr) 2021-04-28
JP2021527639A (ja) 2021-10-14
KR20210021461A (ko) 2021-02-26
BR112020025123A2 (pt) 2021-03-23

Similar Documents

Publication Publication Date Title
GB2576059B (en) A pharmaceutical formulation comprising psilocybin
IL276232A (en) pharmaceutical compounds
GB2569961B (en) Pharmaceutical
GB2572126B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201706327D0 (en) A pharmaceutical compound
GB201810245D0 (en) Pharmaceutical compounds
GB201810239D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
GB201819960D0 (en) Pharmaceutical compounds
GB201801562D0 (en) Pharmaceutical compounds
GB201800378D0 (en) Pharmaceutical compounds
IL279190A (en) A dosage form containing a live biopharmaceutical product
GB201816369D0 (en) Pharmaceutical compounds
ZA202006346B (en) Pharmaceutical preparation
LT3996688T (lt) Farmacinis preparatas
GB201812049D0 (en) Pesticidal dosage form
SG10201912063PA (en) A pharmaceutical formulation
GB201818967D0 (en) A food ingredient
PL3768248T3 (pl) Stała tabletka farmaceutyczna
EP4061369A4 (fr) Forme pharmaceutique comprenant une substance acide
SG10202005831WA (en) A taro-based filled-dough product
GB201814443D0 (en) A pharmaceutical aerosol
AU201817787S (en) A Skirt
AU201817788S (en) A Skirt